Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVDMS plus GC in advanced extrahepatic cholangiocarcinoma
NCT07398339Phase 2Recruiting
- Sponsor
- Shanghai Guangsheng Biopharmaceutical
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cosiporfin sodium in extrahepatic cholangiocarcinoma (eCCA), sponsored by Shanghai Guangsheng Biopharmaceutical. Started Mar 2026; status: recruiting.
02
Drugs
cosiporfin sodium
03
Conditions
extrahepatic cholangiocarcinoma (eCCA)
Beyond the preview
Go deeper on NCT07398339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398339.